SFL is pleased to provide a new training course entitled “Overview of key requirements for combination and substance-based products under MDR” (27^th November, 2019, Basel). Apart from an overview of the MDR’s regulatory system, the course will emphasize implementation requirements to keep processes and portfolios compliant, and products on the market when the MDR finally replaces the existing Medical Device Directive (MDD) legislation in spring 2020.

The course will be given by Karin Schulze (Head of Medical Devices at SFL), Theresa Jeary (Head of Combination Products at SFL), and Stephan Affolter, Head of Quality System & Regulatory Affairs at Ypsomed, under the umbrella of the Medtech & Pharma Platform (MPP).

Registration can be done here.